Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria del Carmen Arango Prado"'
Autor:
Pedro Inocente Mas Bermejo, Maria del Carmen Arango Prado, Rosa Maria Ortiz Reyes, Ania Torres Pombert, Fernando Chuecas, Marcela Cortés‐Jofré, Iraida Caballero Aguirrechu, Rolando Uranga, Cecilia Pacheco
Publikováno v:
Cochrane Database Syst Rev
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of therapeutic vaccines for people with advanced non‐small cell lung cancer (non‐irradiatable stage IIIB and stage IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122319a1d6223d9ff26d3c48d5979f20
https://europepmc.org/articles/PMC6673723/
https://europepmc.org/articles/PMC6673723/
Autor:
Sonia Franco-Odio, Vicente Madrid-Marina, Reyes Tamez-Guerra, Juan Manuel Alcocer-González, Marta Elena Guerra-Yi, Cristina Rodríguez-Padilla, Leticia Llanes-Fernández, Rolando Camacho-Rodríguez, Maria del Carmen Arango-Prado
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 135:255-264
Breast cancer patients may express abnormal cellular immune responses affecting their immunological competence. The analysis of immunological parameters may be useful as indicators of T cell function. To determine the expression of lymphocyte activat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11093d67f252e90a910fb2c7a2873df9
https://doi.org/10.1007/s00432-008-0446-7
https://doi.org/10.1007/s00432-008-0446-7
Autor:
Reyes Tamez-Guerra, Rolando Camacho-Rodríguez, Rosa Irene Álvarez-Goyanes, Vicente Madrid-Marina, Leticia Llanes-Fernández, Sonia Franco Odio, Maiby Orozco López, Juan Manuel Alcocer-González, Marta Elena Guerra-Yi, Julia Cruz Mojarrieta, Maria del Carmen Arango-Prado, Xiomara Escobar Pérez, Cristina Rodríguez-Padilla
Publikováno v:
The Breast. 15:482-489
Tumor markers are expressed due to molecular alterations of the tumor cells, and we can relate them to the immune system to find new associations to improve prognosis. IL-10 inhibits the generation of immune responses at the tumor site. To determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eca11164a43e3604743003656593b70
https://doi.org/10.1016/j.breast.2005.09.012
https://doi.org/10.1016/j.breast.2005.09.012
Publikováno v:
Revista Cubana de Hematología, Inmunología y Hemoterapia
Los avances recientes en la comprensión de los mecanismos génicos y moleculares del cáncer de mama han revelado que el sistema inmune protagoniza los eventos responsables del desarrollo y la progresión del tumor. Las células de la respuesta inmu
Externí odkaz:
https://doaj.org/article/a91404b972d24c5fbafa69d2533579ad